ada.enesco, Author at European Medical Journal - Page 38 of 65

New Monoclonal Antibody Induces Ulcerative Colitis Remission

Tulisokibart, a TNF–like cytokine 1A monoclonal antibody, has demonstrated significant potential in inducing clinical remission in patients with ulcerative colitis.

Long-Term Dermatological Autoimmune Risks Post-COVID-19

COVID-19 increases the long-term risk of autoimmune disorders, especially in severe cases and unvaccinated individuals.

Blood Test Ratios May Predict Mortality in Patients Requiring Hemodialysis

Neutrophil-to-lymphocyte ratio predicts early mortality in older dialysis patients, offering insights for personalised treatment planning.

Study Reveals How Type 2 Diabetes Increases Cardiovascular Risks

Study links type 2 diabetes to impaired fibrous repair in atherosclerotic plaques, highlighting new treatment possibilities.

Bimekizumab Offers Breakthrough Relief for Axial Spondyloarthritis

Bimekizumab reduces pain, stiffness, and fatigue in axial spondyloarthritis, offering a transformative option for managing this chronic condition.

Faster, Accurate Endometriosis Diagnosis with New Biomarker Panel

A novel biomarker panel shows promise for non-invasive endometriosis diagnosis, offering faster, more accurate detection.

Advanced Imaging Reveals Prostate Cancer More Extensive Than Previously Thought

New imaging technique has shown that many cases of prostate cancer may be more advanced than conventional imaging suggests.

ACG Updates Guidelines For Eosinophilic Oesophagitis Management

The latest clinical guidelines from the American College of Gastroenterology (ACG) aim to improve the diagnosis and treatment of eosinophilic oesophagitis.

Can Online Cognitive Behavioural Therapy Improve Atopic Dermatitis?

Self-guided online CBT is noninferior to clinician-guided CBT for atopic dermatitis, offering effective and resource-efficient treatment.

Prenatal Ozone Exposure Linked to Intellectual Disability Risk

Exposure to elevated levels of tropospheric ozone during pregnancy is associated with an increased risk of intellectual disability in children.